Elevated FSH and Low SHBG in Males

What This Pattern Indicates

Elevated FSH with low SHBG in a male suggests two concurrent processes: testicular dysfunction (elevated FSH reflecting impaired spermatogenesis) combined with metabolic derangement (low SHBG indicating insulin resistance, obesity, or metabolic syndrome). 1, 2

Elevated FSH Interpretation

FSH >4.5 IU/L is associated with abnormal semen parameters, particularly reduced sperm concentration and morphology, even when values fall within the traditional "normal" laboratory range of 1.4-18.1 IU/L 2
FSH >7.5 IU/L indicates a 5- to 13-fold increased risk of abnormal semen quality compared to FSH <2.8 IU/L 2
Elevated FSH reflects primary testicular failure (hypergonadotropic hypogonadism), where the pituitary increases FSH output in response to inadequate testicular function 3, 4
The degree of FSH elevation correlates with severity of spermatogenic impairment: mixed atrophy without Sertoli-cell-only (SCO) syndrome shows FSH around 4.5 IU/L, while complete SCO syndrome shows FSH around 16 IU/L 4
"Compensated hypospermatogenesis" describes men with elevated FSH but initially normal semen analysis who are at high risk for progressive decline in sperm parameters over time 5

Low SHBG Interpretation

Low SHBG is defined as <12.3 nmol/L in men <50 years and <23.5 nmol/L in men ≥50 years 6
Low SHBG is strongly associated with obesity, insulin resistance, metabolic syndrome, and type 2 diabetes 1, 7, 6
Additional risk factors include hypothyroidism, Cushing's disease, acromegaly, nonalcoholic fatty liver disease, and nephrotic syndrome 1
Medications that lower SHBG include growth hormone, glucocorticoids, testosterone, and anabolic steroids 1
Low SHBG increases bioavailable testosterone but paradoxically is associated with worse metabolic profiles, increased cardiovascular risk, and higher all-cause mortality 7, 6, 8

Clinical Evaluation Algorithm

Step 1: Confirm Hormonal Abnormalities

Obtain two separate fasting morning (8-10 AM) total testosterone measurements to confirm hypogonadism if testosterone is low 9, 3, 10
Measure LH alongside FSH to distinguish primary (elevated LH and FSH) from secondary (low/normal LH and FSH) hypogonadism 9, 3
If total testosterone is borderline, measure free testosterone by equilibrium dialysis to assess true androgen status when SHBG is abnormal 3, 8
Avoid testosterone testing during acute illness, as results will be unreliable 1

Step 2: Assess for Metabolic and Endocrine Causes of Low SHBG

Calculate body mass index (BMI) and waist circumference to quantify obesity 1, 6
Screen for insulin resistance and type 2 diabetes with fasting glucose and HbA1c 1, 6
Evaluate thyroid function (TSH, free T4) to exclude hypothyroidism 1, 7
Check lipid profile and blood pressure, as low SHBG correlates with dyslipidemia and hypertension 7, 6, 8
Consider screening for nonalcoholic fatty liver disease with liver enzymes and imaging if clinically indicated 1
Review medications that may suppress SHBG (glucocorticoids, growth hormone, exogenous androgens) 1

Step 3: Evaluate Testicular Function and Fertility Status

Obtain semen analysis to assess current fertility potential, as elevated FSH predicts progressive decline in sperm parameters even when baseline analysis is normal 5, 2
Perform testicular examination noting size, consistency, and presence of varicocele 1
If azoospermia is present with elevated FSH, testicular biopsy is unnecessary for diagnosis, as elevated FSH reliably indicates non-obstructive azoospermia 4
Consider genetic counseling and karyotype if severe oligospermia or azoospermia is present 3

Step 4: Screen for Symptoms of Hypogonadism

Assess for sexual symptoms: reduced libido, erectile dysfunction, reduced frequency of intercourse or masturbation, delayed ejaculation 1
Evaluate physical symptoms: hot flushes, decreased energy, reduced muscle strength and physical activity 1
Screen for cognitive symptoms: concentration difficulties, memory problems, sleep disturbances 1
Note that screening questionnaires lack specificity and should not replace formal hormonal evaluation 1, 10

Management Approach

If Fertility Is Desired or Uncertain

Do not prescribe exogenous testosterone, as it will suppress the hypothalamic-pituitary-gonadal axis and worsen spermatogenesis 9
For secondary hypogonadism (low FSH/LH), initiate human chorionic gonadotropin (hCG) 500-2,500 IU subcutaneously 2-3 times weekly to stimulate endogenous testosterone production while preserving fertility 9
After testosterone normalizes on hCG, add FSH injections if needed to optimize spermatogenesis 9
For primary hypogonadism (elevated FSH/LH), fertility options are extremely limited, as the testicular failure is intrinsic; refer to reproductive endocrinology for assisted reproductive technology 3, 4
Offer sperm banking before any hormonal intervention if baseline semen analysis shows any sperm production 9

If Fertility Is Not a Concern and Symptomatic Hypogonadism Is Present

Initiate testosterone replacement therapy only if morning total testosterone is consistently <300 ng/dL and symptoms impair quality of life 3, 10
Screen for contraindications before starting: breast or prostate cancer, PSA >4 ng/mL (or >3 ng/mL with high-risk features), hematocrit >50%, untreated severe obstructive sleep apnea, uncontrolled heart failure, recent MI or stroke within 6 months 3
Formulation options include intramuscular testosterone enanthate/cypionate 75-100 mg weekly, transdermal gel 5-10 g daily, transdermal patch 5 mg nightly, or buccal tablet 30 mg every 12 hours 3
Target serum testosterone 400-700 ng/dL during treatment 3

Address Metabolic Derangements Underlying Low SHBG

Weight loss is the single most effective intervention to raise SHBG and improve metabolic parameters 1, 6
Optimize management of diabetes, hypertension, and dyslipidemia per standard guidelines 6, 8
Treat hypothyroidism if present, as thyroid hormone replacement will increase SHBG 1, 7
Discontinue or minimize glucocorticoids and other SHBG-suppressing medications when possible 1

Monitoring Protocol

For Men on Testosterone Therapy

Re-evaluate at 3-6 months after initiation, then annually 3
At each visit: assess symptom improvement, adverse effects, and measure serum testosterone (for IM formulations, draw ~1 week post-injection) 3
Check hematocrit; discontinue or reduce dose if >54% to prevent polycythemia 3
Measure PSA in men >40 years; refer to urology if PSA rises >1.4 ng/mL within 12 months 3
Monitor for gynecomastia, especially when peripheral aromatization is increased due to obesity 3

For Men with Elevated FSH and Normal Baseline Semen Analysis

Repeat semen analysis every 6-12 months, as these men are at high risk for progressive decline in sperm parameters ("compensated hypospermatogenesis") 5
Close follow-up is warranted even when initial fertility assessment is reassuring 5

Common Clinical Pitfalls

Assuming normal FSH excludes severe spermatogenic dysfunction: FSH <7.6 IU/L does not rule out significant testicular impairment, as individual variation exists 4, 2
Relying solely on total testosterone when SHBG is abnormal: low SHBG increases free testosterone, potentially masking true androgen deficiency; conversely, higher SHBG is independently associated with hypogonadal symptoms even when total testosterone is normal 8
Failing to inquire about fertility intentions before starting testosterone: exogenous testosterone suppresses spermatogenesis, and recovery after cessation is unpredictable and may take months to years 9
Treating asymptomatic men based on laboratory values alone: the benefit-risk balance of testosterone therapy in asymptomatic individuals remains uncertain 3, 10
Ignoring metabolic drivers of low SHBG: addressing obesity, insulin resistance, and metabolic syndrome is essential, as these conditions independently worsen outcomes and may improve with lifestyle intervention 1, 6, 8

What does elevated follicle‑stimulating hormone (FSH) and low sex‑hormone‑binding globulin (SHBG) indicate in a male, and how should it be evaluated and managed?

Have a follow-up question?